Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hyperandrogenism × 1 year × Clear all

Phase

Phase EARLY_PHASE1 3 Phase 2 2 Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 47 Prostatic Neoplasms 22 Neoplasms 19 Multiple Myeloma 16 Papillomavirus Infections 12 Carcinoma, Non-Small-Cell Lung 12 Carcinoma, Hepatocellular 12 Stomach Neoplasms 11 Colorectal Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Lung Neoplasms 9 Pain, Postoperative 8 Neoplasm Metastasis 8 Recurrence 7 Ovarian Neoplasms 7 Waldenstrom Macroglobulinemia 6 Polycystic Ovary Syndrome 6 Melanoma 6 Hematologic Neoplasms 6 Lymphoma, Non-Hodgkin 5 Lymphoma, Follicular 5 Leukemia, Myeloid, Acute 5 Leiomyoma 5 Kidney Neoplasms 5 Agnosia 5 Venous Thromboembolism 4 Urinary Bladder Neoplasms 4 Thyroid Neoplasms 4 Smoking Cessation 4 Pain 4

Interventions

drospirenone and ethinyl estradiol combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03819140 2025-11-14

CCOUP

University of California, San Francisco

Phase 4 Completed

51 enrolled 15 charts

Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡